Immunoassay analyzers are used to identify and detect the concentration of specific substances in a sample, usually using an antibody as a reagent. These devices are used in hospitals and clinical laboratories and can perform a variety of tests including those targeting cancer, allergies, therapeutic drug monitoring and more. According to Gen Consulting Company, the global immunoassay analyzer market is projected to reach USD 6,653 million, recording a CAGR of approximately 4.4 percent from 2022 to 2028.

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global immunoassay analyzer market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the immunoassay analyzer industry.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the technology, end user, and region. The global market for immunoassay analyzer can be segmented by technology: immunofluorescence, chemiluminescence immunoassay (CLIA), radioimmunoassay (RIA), enzyme-linked immunoassay (EIA). Immunoassay analyzer market is further segmented by end user: hospitals, clinical laboratories, pharmaceutical & biotech companies, academia, others. Based on region, the immunoassay analyzer market is segmented into: Asia Pacific, Europe, North America, Rest of the World (RoW).

By technology:
– immunofluorescence
– chemiluminescence immunoassay (CLIA)
– radioimmunoassay (RIA)
– enzyme-linked immunoassay (EIA)

By end user:
– hospitals
– clinical laboratories
– pharmaceutical & biotech companies
– academia
– others

By region:
– Asia Pacific
– Europe
– North America
– Rest of the World (RoW)

The global immunoassay analyzer market report offers detailed information on several market vendors, including Abbott Laboratories, Becton, Dickinson and Company, bioMerieux, Inc., Bio-Rad Laboratories, Inc., Danaher Corporation (Beckman Coulter Inc.), DiaSorin S.p.A., F. Hoffmann-La Roche AG, Meril Life Sciences Pvt. Ltd., Ortho Clinical Diagnostics Holdings plc, Quidel Corporation, Randox Laboratories Ltd., Siemens Healthineers AG, Sysmex Corporation, Thermo Fisher Scientific, Inc., among others.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period
This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.

Scope of the Report
– To analyze and forecast the market size of the global immunoassay analyzer market.
– To classify and forecast the global immunoassay analyzer market based on technology, end user, region.
– To identify drivers and challenges for the global immunoassay analyzer market.
– To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global immunoassay analyzer market.
– To identify and analyze the profile of leading players operating in the global immunoassay analyzer market.

Why Choose This Report
– Gain a reliable outlook of the global immunoassay analyzer market forecasts from 2022 to 2028 across scenarios.
– Identify growth segments for investment.
– Stay ahead of competitors through company profiles and market data.
– The market estimate for ease of analysis across scenarios in Excel format.
– Strategy consulting and research support for three months.
– Print authentication provided for the single-user license.